Gregory L. Carter

Newcastle, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 118 publications

Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

Journal: The British journal of psychiatry : the journal of mental science

Published: July 06, 2026

Suicidal Ideation Effectiveness and Safety Outcomes from the Ketamine for Adult Depression Study (KADS).

Suicidal Ideation Effectiveness and Safety Outcomes from the Ketamine for Adult Depression Study (KADS).

Journal: Archives of suicide research : official journal of the International Academy for Suicide Research

Published: May 09, 2026

Prevalence of somatization syndromes in adult primary care populations: Systematic review, meta-analyses and meta-regressions.

Prevalence of somatization syndromes in adult primary care populations: Systematic review, meta-analyses and meta-regressions.

Journal: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists

Published: May 06, 2026

Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study - RETRACTION.

Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study - RETRACTION.

Journal: The British journal of psychiatry : the journal of mental science

Published: March 31, 2026

A Systematic Review and Meta-Analysis of Telehealth Aftercare Interventions to Reduce Suicidal Behavior or Suicide Following Hospital Treatment in the Emergency Department.

A Systematic Review and Meta-Analysis of Telehealth Aftercare Interventions to Reduce Suicidal Behavior or Suicide Following Hospital Treatment in the Emergency Department.

Journal: Crisis

Published: December 17, 2025

Corrigendum: People who die by suicide without receiving mental health services: a systematic review.

Corrigendum: People who die by suicide without receiving mental health services: a systematic review.

Journal: Frontiers in public health

Published: May 06, 2025

Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study.

Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study.

Journal: The British journal of psychiatry : the journal of mental science

Published: January 07, 2025

Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS study.

Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS study.

Journal: Journal of affective disorders

Published: December 12, 2024

Data-Driven Cutoff Selection for the Patient Health Questionnaire-9 Depression Screening Tool.

Data-Driven Cutoff Selection for the Patient Health Questionnaire-9 Depression Screening Tool.

Journal: JAMA network open

Published: November 22, 2024

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM.

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM.

Journal: The British journal of psychiatry : the journal of mental science

Published: October 14, 2024

Global prevalence of psychosocial assessment following hospital-treated self-harm: systematic review and meta-analysis.

Global prevalence of psychosocial assessment following hospital-treated self-harm: systematic review and meta-analysis.

Journal: BJPsych open

Published: January 11, 2024

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.

Journal: The British journal of psychiatry : the journal of mental science

Published: December 18, 2023

Showing 1-12 of 118

Last Updated: 09/26/2026